ArticleAnnals of surgical oncology2026

ASO Author Reflections: Who Benefits From Adjuvant PD-1 Inhibition? Navigating Time-Dependent Efficacy in Resected HCC.

Bin Guo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.